Superior Safety of Reboxetine Over Amitryptiline in the Elderly

M. W. Agelink, H. Ullrich, P. Passenberg, K. Sayar, N. H. Brockmeyer

Under antidepressive treatment with amitryptiline (100 mg/d) a 71-year old woman developed delirious symptoms, hyponatremia and a grand mal seizure followed by cardiovascular arrest. A few month later she ingested 48 mg reboxetine with suicidal intent.

You can download the whole document by clicking the ZIP image...